[1]
K. Takada, “Effects of inhibition of lymphangiogenesis by the vascular endothelial growth factor receptor 3 (VEGFR-3) inhibitor, MAZ51 on full thickness wounds in mice”, Veins and Lymphatics, vol. 10, no. 1, Mar. 2021.